Elizabeth L. Barry, PhD
Title(s):
Associate Professor of Epidemiology
Associate Professor of Community and Family Medicine
Department(s):
Epidemiology
Community and Family Medicine
Education:
Dartmouth College CECS, MS 2003
University of Wisconsin-Madison, PhD 1989
Grinnell College, BA
Programs:
Norris Cotton Cancer Center
Quantitative Biomedical Sciences
Websites:
https:
http:
Contact Information:
One Medical Center Drive
Rubin Building, Room 857
HB 7927
Lebanon NH 03756
Office: Room 857
Phone: 603-653-9932
Email: elizabeth.l.barry@dartmouth.edu
Professional Interests:
Dr. Barry's current research focuses on the chemoprevention of cancer and the pharmacogenetics of chemopreventative agents. She is especially interested in the role and mechanism of action of anti-inflammatory drugs (such as aspirin) and nutritional supplements (such as calcium, vitamin D and folate) as chemopreventative agents for cancer. Using data from clinical trials, Dr. Barry is currently investigating how genetic polymorphisms may modify the effectiveness of some of these drugs in the prevention of colorectal adenomas. In addition to her interest in cancer, Dr. Barry has a long-standing interest in calcium and vitamin D regulation and their role in bone health and disease (osteoporosis).
Courses Taught:
Medical Pharmacology (Calcium and Bone Pharmacology)
Selected Publications: |
|
Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial. Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Colorectal Adenoma Patients in a Clinical Trial. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Evaluation of a Deep Neural Network for Automated Classification of Colorectal Polyps on Histopathologic Slides. Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial. Vitamin D as Cancer Therapy?: Insights From 2 New Trials. Effects of supplemental calcium and vitamin D on tight-junction proteins and mucin-12 expression in the normal rectal mucosa of colorectal adenoma patients. No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial. Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients. |
|
